Vimarsana
Biggest News Aggregation in the World

Commodore Capital News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Commodore Capital. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Commodore Capital Today - Breaking & Trending Today

Morgan Stanley Reiterates "Overweight" Rating for Pharvaris (NASDAQ:PHVS) - Vimarsana News

Morgan Stanley Reiterates "Overweight" Rating for Pharvaris (NASDAQ:PHVS)

Pharvaris (NASDAQ:PHVS – Get Free Report)‘s stock had its “overweight” rating reiterated by investment analysts at Morgan Stanley in a research report issued to clients and investors on Monday, Benzinga reports. They presently have a $34.00 price target on the stock. Morgan Stanley’s price objective indicates a potential upside of 64.65% from the stock’s previous […]

ABIVAX Société Anonyme (NASDAQ:ABVX) Sees Unusually-High Trading Volume - Vimarsana News

ABIVAX Société Anonyme (NASDAQ:ABVX) Sees Unusually-High Trading Volume

ABIVAX Société Anonyme (NASDAQ:ABVX – Get Free Report) saw unusually-high trading volume on Tuesday . Approximately 76,306 shares were traded during trading, a decline of 1% from the previous session’s volume of 76,878 shares.The stock last traded at $14.27 and had previously closed at $13.97. ABIVAX Société Anonyme Stock Performance The company’s 50 day moving […]

Source: wkrb13.com
Canaccord Genuity Group Boosts Nkarta (NASDAQ:NKTX) Price Target to $16.00 - Vimarsana News

Canaccord Genuity Group Boosts Nkarta (NASDAQ:NKTX) Price Target to $16.00

Nkarta (NASDAQ:NKTX – Free Report) had its price target increased by Canaccord Genuity Group from $15.00 to $16.00 in a research note published on Tuesday, Benzinga reports. The brokerage currently has a buy rating on the stock. A number of other brokerages have also recently weighed in on NKTX. Mizuho decreased their price objective on […]

Biotech Stock News Bite - Avalo Therapeutics, Inc. (NASDAQ: AVTX) Makes NASDAQ Top Gainers List on News it acquired Phase 2-ready anti-IL-1β mAb - Vimarsana News

Biotech Stock News Bite - Avalo Therapeutics, Inc. (NASDAQ: AVTX) Makes NASDAQ Top Gainers List on News it acquired Phase 2-ready anti-IL-1β mAb

Biotech Stock News Bite - Avalo Therapeutics, Inc. (NASDAQ: AVTX) Makes NASDAQ Top Gainers List on News it acquired Phase 2-ready anti-IL-1β mAb

Nkarta (NASDAQ:NKTX) Shares Gap Down to $11.09 - Vimarsana News

Nkarta (NASDAQ:NKTX) Shares Gap Down to $11.09

Nkarta, Inc. (NASDAQ:NKTX – Get Free Report)’s share price gapped down before the market opened on Thursday . The stock had previously closed at $11.09, but opened at $10.80. Nkarta shares last traded at $10.82, with a volume of 70,617 shares. Analyst Ratings Changes Several research analysts have recently weighed in on the stock. Canaccord […]

Source: wkrb13.com